Art

J-GLOBAL ID：201702246294664840   Reference number：17A1943295

Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation

自家幹細胞移植を受けた多発性骨髄腫患者でのシーケンシングに基づいた微小残存病変検出の予後的重要性

Author (20)： TAKAMATSU H. (Kanazawa Univ., Kanazawa) ,  TAKEZAKO N. (National Hospital Organization Disaster Medical Center of Japan, Tachikawa, JPN) ,  ZHENG J. (Adaptive Biotechnologies Corp., South San Francisco, USA) ,  MOORHEAD M. (Adaptive Biotechnologies Corp., South San Francisco, USA) ,  CARLTON V. E. H. (Adaptive Biotechnologies Corp., South San Francisco, USA) ,  KONG K. A. (Adaptive Biotechnologies Corp., South San Francisco, USA) ,  MURATA R. (Keiju Kanazawa Hospital, Kanazawa) ,  ITO S. (Iwate Medical Univ. School of Medicine, Morioka) ,  MIYAMOTO T. (Kyushu Univ., Fukuoka) ,  YOKOYAMA K. (Tokai Univ. Hachioji Hospital, Hachioji) ,  MATSUE K. (Kameda Medical Center, Kamogawa) ,  SATO T. (Sapporo Medical Univ. School of Medicine, Sapporo) ,  KUROKAWA T. (Toyama Red Cross Hospital, Toyama) ,  YAGI H. (Kinki Univ. School of Medicine Nara Hospital, Nara) ,  TERASAKI Y. (Toyama City Hospital, Toyama) ,  OHATA K. (Kanazawa Univ., Kanazawa) ,  MATSUMOTO M. (National Hospital Organization Shibukawa Medical Center, Shibukawa) ,  YOSHIDA T. (Shizuoka City Shimizu Hospital, Shizuoka, JPN) ,  FAHAM M. (Adaptive Biotechnologies Corp., South San Francisco, USA) ,  NAKAO S. (Kanazawa Univ., Kanazawa)
Material： Annals of Oncology  (Ann Oncol)
Volume： 28  Issue： 10  Page： 2503-2510  Publication year： Oct. 2017 
JST Material Number： W0107A  ISSN： 0923-7534  CODEN： ANONE2  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： remaining tumor ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1943295&from=J-GLOBAL&jstjournalNo=W0107A") }}

JST classification (2)： Blood cell tumors(=neoplasms)  (GK04000M) ,  Diagnosis of tumors(=neoplasms)  (GE03020J)

Substance index (1)： Melphalan

Reference (19)：

• International Myeloma Working Group Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003; 121: 749-757.
• Durie BG, Harousseau JL, Miguel JS et al. International uniform response criteria for multiple myeloma. Leukemia 2006; 20: 1467-1473.
• Takamatsu H, Ogawa Y, Kobayashi N et al. Detection of minimal residual disease in patients with multiple myeloma using clonotypespecific PCR primers designed from DNA extracted from archival bone marrow slides. Exp Hematol 2013; 41: 894-902.
• Faham M, Zheng J, Moorhead M et al. Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia. Blood 2012; 120: 5173-5180.
• van der Velden VH, van Dongen JJ. MRD detection in acute lymphoblastic leukemia patients using Ig/TCR gene rearrangements as targets for real-time quantitative PCR. Methods Mol Biol 2009; 538: 115-150.

Terms in the title (5)： 自家幹細胞移植 ,  多発性骨髄腫 ,  患者 ,  微小残存病変 ,  予後的重要性